Product Information
ANAGRELIDE HCL 0.5 MG CAPSULE is a generic product labeled by Torrent Pharmaceuticals Limited, priced at $0.7295 per EA under NDC 13668045301. Its NADAC has been published 439 times since Apr 11, 2018.
FDA first approved this application on Jun 30, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/1
Manufacturer
Torrent Pharmaceuticals LimitedNDC
13668045301
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ANAGRELIDE HYDROCHLORIDE ANHYDROUSApproval Type
Generic (ANDA)
FDA Application
ANDA209151FDA Approved
6/30/2017
TE Code
AB
On Market Since
6/30/2017
Pharmacological Classes
Price Statistics
The NADAC for ANAGRELIDE HCL 0.5 MG CAPSULE has been published 439 times since Apr 11, 2018, and over the history we have for it it has risen 9.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7295 per EA |
|---|---|
| All-time high | $0.7942 (Nov 13, 2019) |
| All-time low | $0.5310 (May 22, 2024) |
| 52-week high | $0.7345 |
| 52-week low | $0.7087 |
| Median price | $0.7154 |
| Average price | $0.6916 |
| Largest weekly change | +20.1% (Aug 21, 2019) |
| Weeks tracked | 439 |
| Tracking since | Apr 11, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the anagrelide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Torrent Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
anagrelide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Platelet-reducing Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ANAGRELIDE HCL 0.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ANAGRELIDE HCL 0.5 MG CAPSULE, manufactured by Torrent Pharmaceuticals Limited, is $0.7295 per EA (NDC 13668045301), effective Sep 30, 2026.
How has the price of ANAGRELIDE HCL 0.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ANAGRELIDE HCL 0.5 MG CAPSULE has risen 9.9%. It has been tracked across 439 weekly CMS publications since Apr 11, 2018.
What are the highest and lowest recorded NADAC prices for ANAGRELIDE HCL 0.5 MG CAPSULE?
Since Apr 11, 2018, the NADAC for ANAGRELIDE HCL 0.5 MG CAPSULE has ranged from a low of $0.5310 (May 22, 2024) to a high of $0.7942 (Nov 13, 2019), with a median of $0.7154 per EA.
Are there cheaper alternatives to ANAGRELIDE HCL 0.5 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of ANAGRELIDE HCL 0.5 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ANAGRELIDE HCL 0.5 MG CAPSULE?
ANAGRELIDE HCL 0.5 MG CAPSULE (NDC 13668045301) is labeled by Torrent Pharmaceuticals Limited, and CMS classifies it as a generic product.